Immune system and malignant disease Flashcards
Why do we give folic acid and how often to patients on methotrexate?
To reduce the possibility of methotrexate toxicity (unlicensed)
Give weekly on different days
Example of Antiproliferate Immunosuppresant
Azathioprine
Mycophenolate
Indication of Azathioprine
IBD. RA, autoimmune condition, suppression of transplant rejection, severe refractory eczema
Important interaction of Azathioprine
Increases the risk of haematological toxicity when given with allopurinol
Reduce the dose of Azathioprine to 1/4 when given with allopurinol
Azathioprine is broken down into
MERCAPTOPURINE
Side effect of Azathioprine
Bone marrow depression, increased risk of infection, leucopenia, thrombocytopenia, pancreatitis.
Nausea
Neutropenia and thrombocytopenia
Side effect of Azathioprine may require drug withdrawal. True/false
True
Side effect of Azathioprine that requires immediate withdrawal
Hypersensitivity rxn such as Dizziness, malaise, rash, N andV, fever
All immuosupressant are teratogenic. True/false
True
Azathioprine pre treatment screening
TPMT enzyme metabolises thiopurine drugs
AbsentTPMT activity- Don’t give thiopurine drugs
Reduced TPMT activity- treat under specialist care
Risk of myelosuppression increases in patients with reduced TPMT activity on Azathioprine. True/false
True
List examples of thiopurine
Tioguanine
Mercaptopurine
Azathioprine
Patient and carer advice for Azathioprine
Report any signs of bone Marrow suppression such as inexplicable bruising or bleeding, infection
Facts about Mycophenolate
Metabolised to mycophenolic acid
More selective MOA than Azathioprine
Incorporating Azathioprine and mycophenolate reduces risk of rejection but higher risk of blood disorder and infection
Caution with mycophenolate
Increased risk of skin cancer ( avoid exposure to strong sunlight)
Risk
Risk of hypogammaglobulinaemia ) ( low antibodies production) or bronchiectasis ( abnormal widening of the bronchi leading to infection when used in combination with other immunosuppresant
State what to do if recurrent infections develop when taking mycophenolate
Measure serum immunoglobulin levels
Consider bronchiectasis or pulmonary fibrosis if persistent respiratory symptoms eh cough and dyspnoea
Conception and contraception with mycophenolate
MHRA advises to exclude pregnancy in women of child bearing potential before treatment
2 pregnancy test 8-10days apart are recommended
Women should use atleast 1 method of contraception before and during tx and for 6weeks after discontinuation
Two method of contraception preferred